Research.Patient.info

Leukaemia research hub

1 indexed studies · 0 currently recruiting

ongoing, recruitingPhase I and Phase II (Integrated)- First administration to humans
Safety, Tolerability and Feasibility of Treatment with GP120-activated Regulatory T cells (ATreg) Early After Haematopoietic Stem Cell Transplantation (HSCT) to Reduce the Incidence and Severity of Acute Graft vs Host Disease (GvHD)
This study looks at a new treatment called ATreg for people with leukaemia who have had a stem cell transplant. It aims to see if ATreg is safe, how well people tolerate it, and if it can help prevent a common complication called GvHD, where the new cells attack the patient's body.
Germany